The treatment of Cancer Risk Reduction & High Cholesterol with vitamins

Cancer Risk Reduction and High Cholesterol: Mitamins custom make quality formulas for the treatment of Cancer Risk Reduction & High Cholesterol with vitamins. A Cancer Risk Reduction & High Cholesterol formula will be made to suit you, using quality brand name ingredients. Mitamins produce custom made vitamin and supplement formulas to suit your individual health needs conveniently in one formula, one bottle and one dosage. For assistance, call toll free: 1-866-585-1390
Your Supplements Facts - Covers the formulas above
Supplement Facts

Specially Formulated for: Cancer Risk Reduction and High Cholesterol

  • Amount Per Serving
    % DV
    Vitamin A
    2500
    IU
    50%
    Vitamin C
    100
    mg
    167%
    Vitamin E
    100
    IU
    333%
    CoQ-10
    15
    mg
    *
    Flax Seed Powder
    50
    mg
    *
    Omega - 3 Fatty Acids
    50
    mg
    *
    Garlic Extract
    50
    mg
    *
  • Amount Per Serving
    % DV
    Grape Seed Extract
    50
    mg
    *
    Green Tea Extract
    50
    mg
    *
    Guggul Extract
    25
    mg
    *
    Soy Isoflavones
    50
    mg
    *
    L-Glutathione Reduced
    100
    mg
    *
    Red Rice Yeast
    100
    mg
    *
    * Daily Value (DV) not established
Name Your Supplement Bottle - Just how you like it
The current default name is: 
 
(Click in box to change)
Your Perfect Supplement - Custom-made just for you
Formulas form 35 Years of Medical Practice
Cancer Risk Reduction and High Cholesterol
Monthly Cost: $39.28
Serving Size:4-5
30 Days Money Back Guarantee
100% Satisfaction Guarantee

Cancer Risk Reduction and High Cholesterol Formulas Details

Customize Your Supplements - Check all that apply
4A Select additional condition(s) you want to address:


4B Select all the medication(s) you are taking:
Update This Formula
If your concern or medication is not listed here, use our Formulator, which covers 680 concerns and 1600 drugs, Click here!
Latest Health Related News:
Tysabri® Demonstrates Significant Health-Related Quality Of Life Improvements For Multiple Sclerosis Patients
Biogen Idec (NASDAQ: BIIB) and Elan Corporation, plc (NYSE: ELN) announced today the publication of results demonstrating that patients treated with TYSABRI® (natalizumab) showed a significant improvement in health-related quality of life (HRQoL) measures when compared to placebo. These results are from the first Phase III multiple sclerosis (MS) studies that have demonstrated improvement on HRQoL measures in patients with relapsing forms of MS.
Jean Chretien Has Quadruple Heart Bypass Surgery
Jean Chretien, former Prime Minister of Canada, 73, had quadruple heart bypass surgery on Wednesday at the Montreal Heart Institute. A hospital spokesperson said he is doing well, and added that the family wished for no further comment on his condition. Chretien had a coronary blockage, surgeons decided to operate before any damage to the heart could happen. He entered hospital on Tuesday and was operated on the following day.
This information concerning the support of Cancer Risk Reduction and High Cholesterol treatments provide basic knowledge which should always be discussed with your own health practitioner.
Any Questions, Call Us Toll Free: 1-866-585-1390
Mitamins Logo
Home  Multi-Conditions formulas  Cancer & Chemo  Cancer Risk Reduction  Cancer Risk Reduction and High Cholesterol
Live Chat System

manufactured In USA

  verisign          Trust E Finalmark

Custom Vitamins and Nutritional Supplements for Supporting Age-Related Cognitive Decline and Aging Treatments